Search Results - Saneeymehri, Seyyedeh

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists

    Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists by Relias, Valerie, McBride, Ali, Newman, Matthew J, Paul, Shilpa, Saneeymehri, Seyyedeh, Stanislaus, Genique, Tobin, Jennifer, Hoang, Caroline J, Ryan, Joanne C, Galinsky, Ilene

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review

    Paradoxical effect of capecitabine in 5-fluorouracil-induced cardiotoxicity: A case vignette and literature review by Saneeymehri, Seyyedeh S, Markey, Kelly R, Mahipal, Amit

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease

    Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease by Saneeymehri, Seyyedeh, Baker, Katherine, So, Tsz-Yin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    The use of brincidofovir for the treatment of mixed dsDNA viral infection

    The use of brincidofovir for the treatment of mixed dsDNA viral infection by Camargo, Jose F., MD, Morris, Michele I, Abbo, Lilian M, Simkins, Jacques, Saneeymehri, Seyyedeh, Alencar, Maritza C, Lekakis, Lazaros J, Komanduri, Krishna V

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    146 - Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients

    146 - Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients by Desai, Amrita, Beitinjaneh, Amer, Ramdial, Jeremy, Ali, Robert, Lekakis, Lazaros, Pereira, Denise, Kimble, Erik, Florou, Vaia, Bravo, Gabriela, Goodman, Mark, Byrnes, John J., Jimenez, Antonio M., Saneeymehri, Seyyedeh, Komanduri, Krishna V.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients

    Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients by Desai, Amrita, Beitinjaneh, Amer, Ramdial, Jeremy, Ali, Robert, Lekakis, Lazaros, Pereira, Denise, Kimble, Erik, Florou, Vaia, Bravo, Gabriela, Goodman, Mark, Byrnes, John J, Jimenez, Antonio M, Saneeymehri, Seyyedeh, Komanduri, Krishna V

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: